Elixir Softlab raises $2 mn to take patient data digital

September 17, 2016 11:42 pm | Updated November 01, 2016 07:12 pm IST - CHENNAI:

The Indian subsidiary of Singapore-based Elixir Lab Pte Ltd., has raised $ 2 million in its quest to take patients data digital and into the mobile space.

Elixir Softlab Solutions Pvt. Ltd., has developed four products -- for doctors, families, pharmacies and labs and hospitals under the hCue brand.

Talking to The Hindu , T. Vijay, founder and head-finance and business development, Elixir Softlab, said: “The core of healthcare data is captured at the level of primary care, which is the starting point to create a unified, comprehensive health record for all.”

According to him, such technology is currently limited to only secondary and tertiary care providers. “Our vision is to enable patients as well as every healthcare provider to get access to that data. Using our software, doctors can create a record within 60 seconds.”

Having raised funding in the last few months, Elixir Softlab has rolled out its services in Chennai.

Currently, it has 800 doctors and 200 pharmacies on its customer rolls and has two lakh patient records. Plans are on to enter Bengaluru, Mumbai, New Delhi, Pune, North America, Australia and South Africa soon.

“As we progressed in our journey, we noticed several inefficiencies in the way pharmacies worked,” said V. Vijay Krishna, founder, heading technology and engineering at Elixir Softlab. “We are building an intelligent system that will use machine learning, artificial intelligence and IoT devices in tandem with healthcare data and genetics,” to help weed out inefficiencies and hence earn more.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.